Gladstone Institutional Advisory’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$725K Buy
10,284
+2,182
+27% +$133K 0.02% 548
2026
Q2
$460K Buy
+8,102
New +$386K 0.01% 613

Other funds holding GNOM

Gladstone Institutional Advisory's GNOM Position: Q3 2026 in Review

Gladstone Institutional Advisory increased its Global X Genomics & Biotechnology ETF (GNOM) stake by 27% in Q3 2026, buying an estimated $133K and bringing the position to 10,284 shares worth $725K. The position accounts for 0.02% of the portfolio, ranked #548.

Gladstone Institutional Advisory first reported a position in GNOM in Q2 2026 and has held it in 2 quarters since. 51 funds tracked by Wall St. Rank hold GNOM as of Q3 2026.

  • Gladstone Institutional Advisory held 10,284 shares of Global X Genomics & Biotechnology ETF worth $725K as of Q3 2026.
  • Gladstone Institutional Advisory bought 2,182 Global X Genomics & Biotechnology ETF shares in Q3 2026, an estimated $133K.
  • Global X Genomics & Biotechnology ETF made up 0.02% of Gladstone Institutional Advisory's portfolio in Q3 2026, its #548 holding.
  • Gladstone Institutional Advisory first reported a position in Global X Genomics & Biotechnology ETF in Q2 2026 and has held it in 2 quarters since.
  • 51 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2026.

Based on Gladstone Institutional Advisory's 13F filing for Q3 2026, filed 13 Nov 2026.